Abstract:Constitutive expression of Kr€ uppel-like factor 3 (KLF3, BKLF) increases marginal zone (MZ) B cell numbers, a phenotype shared with mice lacking KLF2. Ablation of KLF3, known to interact with serum response factor (SRF), or SRF itself, results in fewer MZ B cells. It is unknown how these functional equivalences result. In this study, it is shown that KLF3 acts as transcriptional repressor for the leukocyte-specific integrin b 7 (Itgb7, Ly69) by binding to the b 7 promoter, as revealed by chromatin immuno-precipitation. KLF2 overexpression antagonizes this repression and also binds the b 7 promoter, indicating that these factors may compete for target sequence(s). Whereas b 7 is identified as direct KLF target, its repression by KLF3 is not connected to the MZ B cell increase because b 7-deficient mice have a normal complement of these and the KLF3-driven increase still occurs when b 7 is deleted. Despite this, KLF3 overexpression abolishes lymphocyte homing to Peyer's patches, much like b 7 deficiency does. Furthermore, KLF3 expression alone overcomes the MZ B cell deficiency when SRF is absent. SRF is also dispensable for the KLF3-mediated repression of b 7. Thus, despite the shared phenotype of KLF3 and SRF-deficient mice, cooperation of these factors appears neither relevant for the formation of MZ B cells nor for the regulation of b 7. Finally, a potent negative regulatory feedback loop limiting KLF3 expression is shown in this study, mediated by KLF3 directly repressing its own gene promoter. In summary, KLFs use regulatory circuits to steer lymphocyte maturation and homing and directly control leukocyte integrin expression. K r€ uppel-like factors (KLFs) are zinc finger family transcription factors with 17 members described for mam-malian cells (1). KLFs have a highly conserved DNA binding domain comprised of three C2H2 zinc fingers near or at the C terminus and share similarity to the transcription factors of the specificity protein family (2–5). The KLF zinc fingers are thought to mediate binding to CACCC elements and GC-rich DNA sequences in target genes. In Drosophila Schneider cells, KLF3 (BKLF) had been shown to act as a weak transcriptional activator (6). However, more recent data in murine cells implicate KLF3 as a repressor of transcription (7–9). Indeed, KLF3 has been shown to interact with the common transcriptional corepressors C-terminal binding protein 2 (CtBP2) and four and a half LIM domain protein 3 (FHL3) (8, 10, 11). A further KLF3-interacting transcription factor is …

The kruppel-like factor (KLF) family, diseases, and physiological events

Krüppel-like factors family in health and disease

Krüppel-like factors: three fingers in control

Developmental Expression of Krüppel-like Factors

Krüppel-like factors in bone biology

Kruppel-like Factors(KLFs)and Adipocyte Differentiation

Krϋppel-like factors (KLFs) in renal physiology and disease

KLF/SP Transcription Factor Family Evolution: Expansion, Diversification, and Innovation in Eukaryotes

The role of KLF transcription factor in the regulation of cancer progression

Advance in Biological Function of Kriippel-like Factor 7(KLF7)

KLF transcription factors in bone diseases

Krüppel-like factors in tumors: Key regulators and therapeutic avenues

KLF4 transcription factor in tumorigenesis

Transcription Factor KLF2 and Its Role in the Regulation of Inflammatory Processes

Exploring the Functionality of the Krüppel-like Factors in Kidney Development, Metabolism, and Diseases

Occurrence and significance of the nuclear transcription factor Krüppel-like factor 4 (KLF4) in the vessel wall

This information is current as Krüppel-like Factors Integrin Targeted by 7 β Leukocyte

FBW7-mediated ubiquitination and degradation of KLF5.

Krüppel-like Factor 15: A Potential Therapeutic Target for Kidney Disease

Kruppel-like factors in breast cancer: Function, regulation and clinical relevance

Transcriptional profiling of Krüppel-like factor 4 reveals a function in cell cycle regulation and epithelial differentiation.